Giredestrant
Drug timelines are a Plus or Pro feature.
15 regulatory and trial events tracked for Giredestrant, covering 2023-02-02 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer) [Phase 3]